Fujifilm Medical Systems U.S.A. Inc. recently expanded its breast imaging solutions with the launch of its Tomosynthesis Biopsy option for the Aspire Cristalle mammography system. This new option uses tomosynthesis guidance to calculate 3-D coordinates of a suspicious lesion in the breast, in addition to the traditional stereotactic method. This allows radiologists to accurately complete biopsy of suspicious areas to conduct a pathological examination and inform the diagnosis and care plan. Clinicians will now be able to enhance diagnostic care for patients by using Tomosynthesis Biopsy to target a lesion previously undetectable on images from full field digital mammography (FFDM) alone.
Paul Liu, Ph.D., post-doctoral research associate, Image X Institute at the University of Sydney, Australia, explains ...
Cynthia McCollough, Ph.D., director of the Mayo Clinic Computed Tomography (CT) Clinical Innovation Center, professor of ...
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
Lior Arazi, Ph.D., assistant professor at Ben-Gurion University, Israel, explains the potential benefits of a new Radium ...
Konica Minolta Healthcare Americas Inc. along with Shimadzu Medical Systems USA announced a collaborative agreement to co-market the Dynamic Digital Radiography (DDR) technology in the U.S. healthcare market to accelerate commercialization of the technology in the U.S.

SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Can you tell when someone is lying? Body language expert Traci Brown can. She explained how in a session July 21 at the ...
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
Stephen Sorensen, Ph.D., DABR, chief of medical physics, St. Joseph's Hospital and Medical Center, Phoenix, Arizona ...
Leigh Conroy, Ph.D., physics resident, University Health Network, Princess Margaret Cancer Center, Toronto, Canada ...
For the past twelve years, Canon Medical Systems USA, Inc. has partnered with AHRA: The Association for Medical Imaging ...
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
Efforts to reform healthcare are booming, but finding one that will work well is a challenge. Citing the need to control ...
A recent study projects global market revenues for radiotherapy patient positioning accessories will exceed revenues of $500 million in 2019. This represents a moderate 4.3 percent annual growth over 2018, with nearly 1/5 of the overall installed base of radiotherapy patient positioning accessories accounted for by couch tops and overlays, followed by immobilization systems.
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer among women across the world. From our perspective, improved treatment options and earlier detection could have a positive impact on decreasing mortality, as this could offer more options for successful intervention and therapies when the disease is still in its early stages.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
Ron Blankstein, M.D., director of cardiac computed tomography, Brigham and Women's Hospital, and associate professor of ...
Quynh Truong, M.D., MPH, associate professor of radiology and medicine at Weill Cornell and director of cardiac CT ...
Rural America does not show up in any atlas but, geographically, it accounts for 80 percent of the United States’ land ...
Recent advances in digital radiography (DR) are increasing demand for whole spine imaging before, during and after back ...
Low doses of radiation equivalent to three computed tomography (CT) scans, which are considered safe, give cancer-capable cells a competitive advantage over normal cells in healthy tissue, scientists have discovered. Researchers at the Wellcome Sanger Institute and the University of Cambridge studied the effects of low doses of radiation in the esophagus of mice.
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are now ...
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded to harness the value of artificial intelligence (AI) to improve medical outcomes. Qlarity Imaging will further develop QuantX, the U.S. Food and Drug Administration (FDA)-cleared computer-aided breast cancer diagnosis system.
On June 30, 2019, the Centers for Medicare & Medicaid Services (CMS) announced the Johns Hopkins University School of Medicine has been designated a qualified provider-led entity (qPLE). This allows Johns Hopkins to develop criteria that meet the requirements of the federal Protecting Access to Medicare Act (PAMA) of 2014 when ordering diagnostic imaging tests such as computed tomography (CT) scans, magnetic resonance imaging (MRI) scans and nuclear imaging in the emergency department and ambulatory settings.